Supplemental material
Open access
1,934
Views
5
CrossRef citations to date
0
Altmetric
Pain Medicine
Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe pain
Mario F. P. Peresa Neurology, Hospital Israelita Albert Einstein, São Paulo, Brazil;b Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina, São Paulo, Brazilhttps://orcid.org/0000-0002-0068-1905
, Raghavendra Vasudevac Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
, Simin K. Bayganic Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
, Ellen B. Dennehyc Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA;d Psychological Sciences, Purdue University, West Lafayette, IN, USA
, Maurice Vincentc Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USAhttps://orcid.org/0000-0001-5855-6069
& Deborah I. Friedmane Neurology and Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, USA
Pages 1031-1038
|
Received 14 Dec 2020, Accepted 11 Mar 2021, Published online: 07 Apr 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.